-
Xconomy Boston
-
Xperience
Tech + Life▾-
-
![Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.]()
Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
-
![Scouting for a Summer Camp for the Kids? Camperoo, Sigby Offer Aid]()
Scouting for a Summer Camp for the Kids? Camperoo, Sigby Offer Aid
-
![Tips from TravelNerd Offer a Smoother Ride Through the Airport]()
Tips from TravelNerd Offer a Smoother Ride Through the Airport
-
![Coffee Goes from Folger’s, to Starbucks, to Tech-Driven ‘Third Wave’]()
Coffee Goes from Folger’s, to Starbucks, to Tech-Driven ‘Third Wave’
-
![Get to Know Your College Town With Guidesmob’s Apps]()
Get to Know Your College Town With Guidesmob’s Apps
-
-
-
Our
Cities▾-
Tech
Channels ▾ -
Meet the
Xconomists ▾-
![mramsinghani]()
Mahendra Ramsinghani
-
![bcravatt]()
Benjamin Cravatt
Chair of the Dept. of Chemical Physiology, The Scripps Research Institute
-
![eschadt]()
Eric Schadt
Dir., Mt. Sinai Institute for Genomics and Multi-Scale Biology
-
![kcoburn]()
Kirk Coburn
Founder & Managing Director, SURGE Accelerator
- Meet All the Xconomists ›
-
![rnewton]()
Roger Newton
Founder and CEO, Esperion Therapeutics
-
![nglaros]()
Nicole Glaros
Co-managing director, TechStars Boulder and New York City
-
Paul A. Bleicher
Chief Medical Officer, Humedica
-
![cherron]()
Christine Herron
Director, Intel Capital
-
-
Our
Events ▾ -
-
-
-
-
From In Comeback Study, Acadia Says Drug Controls Parkinson’s Psychosis:
Acadia Logo(R)—Acadia Pharmaceuticals logo
Underwriters and Partners
Connect with Xconomy
Xconomy’s Most Popular
Xconomy on Demand
Did you miss something? Don't despair…
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
-
Tech
